LPH: Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented
What it covers
A hip joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis is a device intended to be implanted to replace a hip joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across the joint. This generic type of device has a femoral component made of a cobalt-chromium-molybdenum (Co-Cr-Mo) alloy or a titanium-aluminum-vanadium (Ti-6Al-4V) alloy and an acetabular component composed of an ultra-high molecular weight polyethylene articulating bearing surface fixed in a metal shell made of Co-Cr-Mo or Ti-6Al-4V. The femoral stem and acetabular shell have a porous coating made of, in the case of Co-Cr-Mo substrates, beads of the same alloy, and in the case of Ti-6Al-4V substrates, fibers of commercially pure titanium or Ti-6Al-4V alloy. The porous coating has a volume porosity between 30 and 70 percent, an average pore size between 100 and 1,000 microns, interconnecting porosity, and a porous coating thickness between 500 and 1,500 microns. The generic type of device has a design to achieve biological fixation to bone without the use of bone cement.
The identification in 21 CFR 888.3358, hip joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis. FDA gives LPH no definition of its own, so the regulation’s describes it.
FDA flags LPH devices as implants.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K261453 | G7® Acetabular System | Zimmer Biomet | Sep 23, 2026 | Traditional |
| K253630 | Mpact 3D Metal Foam | Medacta International S.A. | Aug 28, 2026 | Traditional |
| K254043 | TRIVANCE Hip Stem | Globus Medical, Inc. | Aug 4, 2026 | Traditional |
| K261624 | Omnifit® 20° Series I Insert;Omnifit® Crossfire® 10° Series II Insert; Constrained Acetabular Insert; Trident® Crossfire® 0° Polyethylene Insert; Trident ® Crossfire ® 10° Polyethylene Insert;System 12 Crossfire® 10° Insert; Trident® 0° Constrained Acetabular Insert; Trident® Constrained Acetabular Liner;Trident® All Poly Constrained Acetabular Insert; Crossfire® Eccentric Insert 10°; Artisan® Bone Plug;UHR® Universal Head Bipolar Component | Howmedica Osteonics Corp., Dba Stryker Orthopaedics | Jul 10, 2026 | Traditional |
| K243192 | iNSitu Lateralized Acetabular Liners, iNSitu Femoral Stems with Plasma Sprayed CPTi Coating | Nextstep Arthopedix, LLC | Jun 5, 2026 | Traditional |
| K251270 | Taperloc® Complete Hip Stem | Biomet, Inc. | May 19, 2026 | Traditional |
| K252623 | G7® Revision Acetabular System | Zimmer, Inc. | Feb 4, 2026 | Traditional |
| K251043 | Mpact 3D Metal Implants Extension DMLS Technology | Medacta International S.A. | Jan 28, 2026 | Traditional |
| K252067 | Velora Acetabular System | Restor3D, Inc. | Dec 5, 2025 | Traditional |
| K252846 | TaperSet Hip System | Shalby Advanced Technologies, Inc. Dba Consensus Orthopedics | Nov 20, 2025 | Special |
Clearances by year
208 LPH 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 8 | 256 |
| 2025 | 12 | 153 |
| 2024 | 6 | 92 |
| 2023 | 10 | 111 |
| 2022 | 14 | 247 |
| 2021 | 8 | 410 |
| 2020 | 7 | 164 |
| 2019 | 22 | 164 |
| 2018 | 9 | 145 |
| 2017 | 12 | 121 |
| 2016 | 10 | 150 |
| 2015 | 18 | 111 |
| 2014 | 20 | 129 |
| 2013 | 11 | 135 |
| 2012 | 25 | 76 |
| 2011 | 16 | 110 |
Who submits
70 applicants cleared a LPH device since 2011. 73% of the clearances went to applicants in United States, then Taiwan (6%), South Korea (5%) and Switzerland (5%). By type: Traditional 71%, Special 28% and Abbreviated 0%.
| Applicant | Clearances since 2011 |
|---|---|
| Smith & Nephew, Inc. | 17 |
| Corentec Co., Ltd. | 12 |
| United Orthopedic Corporation | 10 |
| Biomet, Inc. | 9 |
| Zimmer, Inc. | 9 |
| Lima Corporate S.P.A. | 8 |
| Medacta International S.A. | 8 |
| Encore Medical L.P. | 7 |
How FDA classifies it
Class II.
From 21 CFR 888.3358.
Standards
21 CFR 888.3358 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent LPH clearances declared.
Ask about LPH
Questions about LPH
What is FDA product code LPH?
Product code LPH, “Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented” in FDA's classification database, is a Class II device type under 21 CFR 888.3358 (hip joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis), reviewed by FDA's Orthopedic panel. FDA's 510(k) database lists 565 clearances under LPH, 208 of them since 2011.
How many 510(k) clearances are there under LPH?
FDA’s 510(k) database listed 565 clearances under LPH as of Oct 29, 2026, 208 of them decided since 2011; the most recent decision was Sep 23, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a LPH 510(k)?
For the 21 LPH clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 169 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most LPH clearances?
Since 2011: Smith & Nephew, Inc. (17), Corentec Co., Ltd. (12), United Orthopedic Corporation (10), Biomet, Inc. (9) and Zimmer, Inc. (9). 70 applicants have cleared a LPH device in that time.